Myrbetriq 00469-5020
Generic: Mirabegron
Product NDC
00469-5020- Manufacturer
- Astellas Pharma Us, Inc.
- Dosage Form
- Granule, For Suspension, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- March 25, 2021
- Listing Expires
- December 31, 2026
- Application
- NDA213801
Need to source Myrbetriq? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Mirabegron | 8 mg/mL |
Drug Class
beta3-Adrenergic Agonist [EPC]Adrenergic beta3-Agonists [MoA]Cytochrome P450 2D6 Inhibitors [MoA]
Packaging Options(1)
1 BOTTLE in 1 CARTON (0469-5020-99) / 100 mL in 1 BOTTLE